Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
411
-
Total 13F shares, excl. options
-
90.9M
-
Shares change
-
+2.21M
-
Total reported value, excl. options
-
$13.6B
-
Value change
-
+$328M
-
Put/Call ratio
-
0.82
-
Number of buys
-
205
-
Number of sells
-
-188
-
Price
-
$149.24
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q3 2019
498 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q3 2019.
DEXCOM INC - Common Stock (DXCM) has 411 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.9M shares
of 392M outstanding shares and own 23.22% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.4M shares), FMR LLC (7.06M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.29M shares), BlackRock Inc. (5.31M shares), BAILLIE GIFFORD & CO (4.83M shares), Capital World Investors (4.1M shares), JENNISON ASSOCIATES LLC (4.04M shares), JPMORGAN CHASE & CO (3.61M shares), MORGAN STANLEY (3.13M shares), and BROWN ADVISORY INC (2.52M shares).
This table shows the top 411 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.